Hyperfine, Inc. (NASDAQ:HYPR - Get Free Report)'s stock price was up 8.2% on Friday . The stock traded as high as $1.10 and last traded at $1.06. Approximately 328,884 shares changed hands during trading, an increase of 6% from the average daily volume of 310,742 shares. The stock had previously closed at $0.98.
Hyperfine Price Performance
The company has a fifty day moving average price of $0.95 and a two-hundred day moving average price of $1.00. The company has a market capitalization of $77.33 million, a P/E ratio of -1.86 and a beta of 0.86.
Hyperfine (NASDAQ:HYPR - Get Free Report) last announced its quarterly earnings results on Tuesday, November 12th. The company reported ($0.14) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.14). The firm had revenue of $3.64 million during the quarter, compared to analysts' expectations of $3.40 million. Hyperfine had a negative net margin of 309.42% and a negative return on equity of 57.54%. During the same period in the prior year, the company posted ($0.15) EPS. As a group, sell-side analysts forecast that Hyperfine, Inc. will post -0.57 earnings per share for the current year.
Institutional Trading of Hyperfine
A hedge fund recently raised its stake in Hyperfine stock. Geode Capital Management LLC lifted its stake in shares of Hyperfine, Inc. (NASDAQ:HYPR - Free Report) by 18.7% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 624,520 shares of the company's stock after buying an additional 98,335 shares during the quarter. Geode Capital Management LLC owned about 0.86% of Hyperfine worth $675,000 as of its most recent filing with the Securities & Exchange Commission. 15.03% of the stock is owned by institutional investors and hedge funds.
Hyperfine Company Profile
(
Get Free Report)
Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.
Read More
Before you consider Hyperfine, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hyperfine wasn't on the list.
While Hyperfine currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
